Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
KBW Prem Yield Equity REIT Powershares | KBWY | Nov 15, 2024 | 19.43 | 0.00 |
KBW Prop & Casuality Insur Powershares | KBWP | Nov 15, 2024 | 121.47 | +0.76 |
KBW Regional Banking Powershares | KBWR | Nov 15, 2024 | 65.25 | +0.01 |
KE Holdings | BEKE | Nov 15, 2024 | 19.52 | +0.83 |
Kearny Financial | KRNY | Nov 15, 2024 | 8.21 | -0.12 |
Keen Vision Acquisition | KVACU | Nov 15, 2024 | 10.99 | 0.00 |
Keen Vision Acquisition | KVAC | Nov 15, 2024 | 10.87 | 0.00 |
Kellanova | K | Nov 15, 2024 | 80.57 | -0.35 |
Kelly Services A | KELYA | Nov 15, 2024 | 14.39 | -4.39 |
Kelly Services B | KELYB | Nov 15, 2024 | 16.07 | 0.00 |
Kemper | KMPR | Nov 15, 2024 | 71.24 | +0.84 |
Kennametal | KMT | Nov 15, 2024 | 28.46 | -0.80 |
Kennedy-Wilson | KW | Nov 15, 2024 | 10.82 | 0.00 |
Kenon Holdings | KEN | Nov 15, 2024 | 28.99 | -0.65 |
Kentucky First Federal Bancorp | KFFB | Nov 15, 2024 | 2.56 | -5.19 |
Kenvue | KVUE | Nov 15, 2024 | 23.82 | +0.89 |
Keros Therapeutics | KROS | Nov 15, 2024 | 56.62 | -6.18 |
Keurig Dr Pepper | KDP | Nov 15, 2024 | 31.66 | -5.15 |
Kewaunee Scientific | KEQU | Nov 15, 2024 | 37.90 | -0.50 |
Key Tronic | KTCC | Nov 15, 2024 | 5.79 | -1.53 |
KeyCorp | KEY-L | Nov 15, 2024 | 24.95 | -0.28 |
KeyCorp | KEY | Nov 15, 2024 | 19.16 | +0.10 |
Keycorp Pref E | KEY-I | Nov 15, 2024 | 25.00 | +0.44 |
Keycorp Pref F | KEY-J | Nov 15, 2024 | 23.32 | +0.78 |
Keycorp Pref G | KEY-K | Nov 15, 2024 | 23.75 | +0.42 |
Keysight Technologies | KEYS | Nov 15, 2024 | 149.37 | -2.80 |
Kezar Life Sciences | KZR | Nov 15, 2024 | 7.46 | -0.80 |
KFA Global Carbon ETF | KRBN | Nov 15, 2024 | 31.01 | -1.68 |
Kforce | KFRC | Nov 15, 2024 | 58.18 | -2.07 |
Kidpik | PIK | Nov 15, 2024 | 2.26 | -3.83 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.